- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 521.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 519.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 478.72M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $38M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1M |
| Capex | Q1 2026 · Mar 31, 2026 | $37M |
| Capex | Q1 2026 · Mar 31, 2025 | $27M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$15M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $53M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.46B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.36B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $62M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $58M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $442M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $434M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.61B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.61B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.49B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.38B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.42B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.26B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.76B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.57B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.08B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.92B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.10 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.16 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.16 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $98M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $68M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $55M |
| Revenue | Q1 2026 · Mar 31, 2026 | $840M |
| Revenue | Q1 2026 · Mar 31, 2025 | $621M |